{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:09:19Z","timestamp":1789834159658,"version":"4.0.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 HL141651"],"award-info":[{"award-number":["K23 HL141651"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cll.2024.04.011","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:58:38Z","timestamp":1717577918000},"page":"511-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Flow Cytometry and Platelets"],"prefix":"10.1016","volume":"44","author":[{"suffix":"III","given":"Andrew L.","family":"Frelinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.cll.2024.04.011_bib1","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.101.23.2690","article-title":"High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14","volume":"101","author":"Coulter","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1538-7836.2009.03659.x","article-title":"Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication","volume":"8","author":"Stellos","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib3","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2004-06-2098","article-title":"Platelet activation in cystic fibrosis","volume":"105","author":"O'Sullivan","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2024.04.011_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/01.CIR.102.8.890","article-title":"Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy","volume":"102","author":"Fateh-Moghadam","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cll.2024.04.011_bib5","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/dc13-2718","article-title":"Markers of platelet activation are increased in adolescents with type 2 diabetes","volume":"37","author":"Israels","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000054726","article-title":"Platelet GPIIb\/IIIa is activated and platelet-leukocyte coaggregates formed in\u00a0vivo during hemodialysis","volume":"90","author":"Kawabata","year":"2002","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11239-007-0047-3","article-title":"Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease","volume":"25","author":"Serebruany","year":"2008","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.cll.2024.04.011_bib8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021012064","article-title":"A\u00a0Flow cytometric assay to detect platelet activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","author":"Handtke","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v14061133","article-title":"Detection of platelet-activating antibodies associated with vaccine-induced thrombotic thrombocytopenia by flow cytometry: an Italian experience","volume":"14","author":"Cesari","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib10","first-page":"298","article-title":"Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia","volume":"80","author":"Grau","year":"1998","journal-title":"Thromb Haemostasis"},{"issue":"2\u20133","key":"10.1016\/j.cll.2024.04.011_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/cs0860731","article-title":"Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy","volume":"86","author":"Janes","year":"1994","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-9378(97)70212-6","article-title":"Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study","volume":"177","author":"Konijnenberg","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/09537104.2013.770136","article-title":"Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study","volume":"25","author":"Frelinger","year":"2013","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib16","doi-asserted-by":"crossref","first-page":"e99386","DOI":"10.1371\/journal.pone.0099386","article-title":"Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus","volume":"9","author":"Lood","year":"2014","journal-title":"PLoS One"},{"issue":"Pt 6","key":"10.1016\/j.cll.2024.04.011_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/acb.2012.011215","article-title":"Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis","volume":"49","author":"Woth","year":"2012","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s001340050344","article-title":"Platelet function in septic multiple organ dysfunction syndrome","volume":"23","author":"Gawaz","year":"1997","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2141.2001.03101.x","article-title":"Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis","volume":"115","author":"Joseph","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00024382-200204000-00004","article-title":"Platelet and leukocyte activation correlate with the severity of septic organ dysfunction","volume":"17","author":"Russwurm","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.cll.2024.04.011_bib21","series-title":"Platelets","first-page":"329","article-title":"Platelet signal transduction","author":"Lee","year":"2019"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0021-9258(19)75739-1","article-title":"Induction of the fibrinogen receptor on human platelets by intracellular mediators","volume":"262","author":"Shattil","year":"1987","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cll.2024.04.011_bib23","series-title":"Platelets","first-page":"349","article-title":"Platelet secretion","author":"Flaumenhaft","year":"2019"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib24","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI116388","article-title":"The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin","volume":"91","author":"Nishibori","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"16","key":"10.1016\/j.cll.2024.04.011_bib25","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2004-01-0315","article-title":"A\u00a0TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets","volume":"104","author":"Washington","year":"2004","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.cll.2024.04.011_bib27","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1182\/blood-2018-03-841593","article-title":"Platelet-derived TLT-1 is a prognostic indicator in ALI\/ARDS and prevents tissue damage in the lungs in a mouse model","volume":"132","author":"Morales-Ortiz","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2004-06-2282","article-title":"Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation","volume":"105","author":"Pitchford","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib29","first-page":"338","article-title":"All platelets are not equal: COAT platelets","volume":"3","author":"Alberio","year":"2004","journal-title":"Curr Hematol Rep"},{"issue":"10","key":"10.1016\/j.cll.2024.04.011_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/j.1538-7836.2005.01274.x","article-title":"Coated-platelets: an emerging component of the procoagulant response","volume":"3","author":"Dale","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cll.2024.04.011_bib31","series-title":"Platelets","first-page":"401","article-title":"Platelet-derived extracellular vesicles","author":"Gasecka","year":"2019"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Subcommittee on platelet physiology of the international society on thrombosis and hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.14683","article-title":"Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC","volume":"18","author":"Gresele","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/hae.14578","article-title":"Platelet function testing: current practice among clinical centres in Northern Europe","volume":"28","author":"Szanto","year":"2022","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib35","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/jth.15526","article-title":"Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: communication from the ISTH SSC Subcommittee on Platelet Physiology","volume":"19","author":"Frelinger","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cll.2024.04.011_bib36","series-title":"Platelets","first-page":"627","article-title":"Flow cytometry","author":"Blair","year":"2019"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib37","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1002\/cpz1.178","article-title":"3rd. Immunophenotypic analysis of platelets by flow cytometry","volume":"1","author":"Spurgeon","year":"2021","journal-title":"Curr Protoc"},{"issue":"7","key":"10.1016\/j.cll.2024.04.011_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102205","article-title":"Preanalytical conditions for multiparameter platelet flow cytometry","volume":"7","author":"Hindle","year":"2023","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-3148.1999.00188.x","article-title":"Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant","volume":"9","author":"Mody","year":"1999","journal-title":"Transfus Med"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.thromres.2011.11.031","article-title":"Whole blood flow cytometry measurements of in\u00a0vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques","volume":"129","author":"Rondina","year":"2012","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09537104.2017.1353684","article-title":"Platelet function investigation by flow cytometry: sample volume, needle size, and reference intervals","volume":"29","author":"Pedersen","year":"2018","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/09537104.2018.1535705","article-title":"Agreement between blood draw techniques for assessing platelet activation by flow cytometry","volume":"30","author":"Welch","year":"2019","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1538-7836.2007.02462.x","article-title":"Indices of platelet activation and the stability of coronary artery disease","volume":"5","author":"Linden","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2004.04983.x","article-title":"Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack","volume":"125","author":"McCabe","year":"2004","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.cll.2024.04.011_bib45","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2024.04.011_bib46","first-page":"1","article-title":"Leukocyte-platelet aggregates-a phenotypic characterization of different stages of peripheral arterial disease","author":"Dopheide","year":"2016","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib47","first-page":"529","article-title":"Platelet activation and alzheimer's disease: the probable role of PI3K\/AKT pathway","volume":"90","author":"Khezri","year":"2022","journal-title":"J\u00a0Alzheim Dis"},{"issue":"7","key":"10.1016\/j.cll.2024.04.011_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/09537100903221001","article-title":"Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity","volume":"20","author":"Tarnow","year":"2009","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cam4.86","article-title":"Increased platelet reactivity in patients with late-stage metastatic cancer","volume":"2","author":"Cooke","year":"2013","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib50","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1055\/s-0038-1656093","article-title":"Platelet hyporeactivity in very low birth weight neonates","volume":"77","author":"Rajasekhar","year":"1997","journal-title":"Thromb Haemostasis"},{"issue":"16","key":"10.1016\/j.cll.2024.04.011_bib51","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/bloodadvances.2023009824","article-title":"Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: the PLINIUS study","volume":"7","author":"Weiss","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.cll.2024.04.011_bib52","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/ATVBAHA.120.316772","article-title":"Identification of a distinct platelet phenotype in the elderly: ADP hypersensitivity coexists with platelet PAR (Protease-Activated receptor)-1 and PAR-4-mediated thrombin resistance","volume":"42","author":"Gnanenthiran","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V61.1.99.99","article-title":"Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor","volume":"61","author":"Coller","year":"1983","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.cll.2024.04.011_bib54","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1016\/S0021-9258(19)85139-6","article-title":"Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex","volume":"260","author":"Parise","year":"1985","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib55","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI109597","article-title":"Exposure of platelet fibrinogen receptors by ADP and epinephrine","volume":"64","author":"Bennett","year":"1979","journal-title":"J\u00a0Clin Invest"},{"issue":"20","key":"10.1016\/j.cll.2024.04.011_bib56","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","article-title":"Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation","volume":"260","author":"Shattil","year":"1985","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib57","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V68.6.1224.1224","article-title":"Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine","volume":"68","author":"Shattil","year":"1986","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V70.1.307.307","article-title":"Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry","volume":"70","author":"Shattil","year":"1987","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0038-1648173","article-title":"Immunological detection of activated platelets in clinical disorders","volume":"65","author":"Abrams","year":"1991","journal-title":"Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V75.1.128.128","article-title":"Direct detection of activated platelets and platelet-derived microparticles in humans","volume":"75","author":"Abrams","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cll.2024.04.011_bib61","first-page":"1","article-title":"Using flow cytometry to monitor glycoprotein IIb-IIIa activation","author":"Frelinger","year":"2018","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0049-3848(87)90086-7","article-title":"Analysis of distribution of receptors among platelets by flow cytometry","volume":"45","author":"Kasahara","year":"1987","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2141.1989.tb07724.x","article-title":"Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: analysis by flow cytometry","volume":"72","author":"Jackson","year":"1989","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-4889(87)90065-6","article-title":"An investigation of fibrin-platelet adhesive interactions by microfluorimetry","volume":"927","author":"Hantgan","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib65","first-page":"728","article-title":"Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry","volume":"123","author":"Faraday","year":"1994","journal-title":"J\u00a0Lab Clin Med"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cyto.990170403","article-title":"Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets","volume":"17","author":"Heilmann","year":"1994","journal-title":"Cytometry"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib67","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1124\/jpet.107.122853","article-title":"Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling","volume":"322","author":"Marwali","year":"2007","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib68","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2007-09-110437","article-title":"RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase","volume":"112","author":"Su","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2024.04.011_bib69","doi-asserted-by":"crossref","first-page":"e0166136","DOI":"10.1371\/journal.pone.0166136","article-title":"Functional effect of the mutations similar to the cleavage during platelet activation at integrin beta3 cytoplasmic tail when expressed in mouse platelets","volume":"11","author":"Shi","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cll.2024.04.011_bib70","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20130477","article-title":"Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding","volume":"211","author":"Canault","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"24","key":"10.1016\/j.cll.2024.04.011_bib71","doi-asserted-by":"crossref","first-page":"16193","DOI":"10.1016\/S0021-9258(18)98534-0","article-title":"A\u00a0receptor-induced binding site in fibrinogen elicited by its interaction with platelet membrane glycoprotein IIb-IIIa","volume":"266","author":"Zamarron","year":"1991","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.1992.tb08144.x","article-title":"Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen","volume":"80","author":"Gralnick","year":"1992","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib73","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1990.tb06373.x","article-title":"Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation","volume":"76","author":"Warkentin","year":"1990","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib74","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/nprot.2012.126","article-title":"Quality assurance for polychromatic flow cytometry using a suite of calibration beads","volume":"7","author":"Perfetto","year":"2012","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib75","doi-asserted-by":"crossref","first-page":"e0192079","DOI":"10.1371\/journal.pone.0192079","article-title":"Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test","volume":"13","author":"Huskens","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cll.2024.04.011_bib76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4939-7196-1_28","article-title":"Flow cytometry protocols for assessment of platelet function in whole blood","volume":"1646","author":"Pasalic","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.cll.2024.04.011_bib77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jcp.15.5.452","article-title":"Platelet aggregation: Part II Some results from a new method of study","volume":"15","author":"O'Brien","year":"1962","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cll.2024.04.011_bib78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cll.2024.04.011_bib79","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1182\/blood-2012-06-437723","article-title":"A\u00a0novel flow cytometry-based platelet aggregation assay","volume":"121","author":"De Cuyper","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib80","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jth.13675","article-title":"Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach","volume":"15","author":"Vinholt","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(89)90292-4","article-title":"PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes","volume":"59","author":"Larsen","year":"1989","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib82","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood.V75.3.550.550","article-title":"GMP-140 mediates adhesion of stimulated platelets to neutrophils","volume":"75","author":"Hamburger","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib83","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0038-1642681","article-title":"The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1","volume":"74","author":"Furie","year":"1995","journal-title":"Thromb Haemostasis"},{"issue":"13","key":"10.1016\/j.cll.2024.04.011_bib84","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/hc3801.095588","article-title":"Circulating monocyte-platelet aggregates are a more sensitive marker of in\u00a0vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction","volume":"104","author":"Michelson","year":"2001","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.cll.2024.04.011_bib85","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1073\/pnas.93.21.11877","article-title":"In\u00a0vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function","volume":"93","author":"Michelson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2024.04.011_bib86","first-page":"6 15 1","article-title":"Whole blood analysis of leukocyte-platelet aggregates","volume":"78","author":"Gerrits","year":"2016","journal-title":"Current protocols in cytometry\/editorial board, J Paul Robinson, managing editor [et\u00a0al]"},{"issue":"24","key":"10.1016\/j.cll.2024.04.011_bib87","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","article-title":"Soluble P-selectin and the risk of future cardiovascular events","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2024.04.011_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-5-27","article-title":"Evidence of platelet activation in multiple sclerosis","volume":"5","author":"Sheremata","year":"2008","journal-title":"J\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib90","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(01)01485-1","article-title":"Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction","volume":"38","author":"Furman","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cll.2024.04.011_bib91","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2016.10.002","article-title":"Imaging flow cytometry in the assessment of leukocyte-platelet aggregates","volume":"112","author":"Hui","year":"2017","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.cll.2024.04.011_bib92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09537104.2018.1430358","article-title":"Measuring and interpreting platelet-leukocyte aggregates","volume":"29","author":"Finsterbusch","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.cll.2024.04.011_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2018.12.029","article-title":"Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease","volume":"282","author":"Allen","year":"2019","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib94","first-page":"400","article-title":"Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: implications for diagnosing suspected platelet function disorders due to dense granule deficiency","volume":"40","author":"Brunet","year":"2018","journal-title":"Int J Lit Humanit"},{"key":"10.1016\/j.cll.2024.04.011_bib95","series-title":"Platelets","first-page":"259","article-title":"The platelet P2 receptors","author":"Cattaneo","year":"2019"},{"issue":"8","key":"10.1016\/j.cll.2024.04.011_bib96","article-title":"Platelet delta-storage pool disease: an update","volume":"9","author":"Dupuis","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.1995.tb08901.x","article-title":"Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry","volume":"89","author":"Gordon","year":"1995","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1016\/j.cll.2024.04.011_bib98","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/bloodadvances.2017006726","article-title":"Platelet dense granules begin to selectively accumulate mepacrine during proplatelet formation","volume":"1","author":"Hanby","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib99","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0035-1564836","article-title":"Usefulness of flow cytometric mepacrine uptake\/release combined with CD63 assay in diagnosis of patients with suspected platelet dense granule disorder","volume":"42","author":"Cai","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1995.tb03315.x","article-title":"A\u00a0flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents","volume":"89","author":"Wall","year":"1995","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH14-11-0999","article-title":"A\u00a0review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders","volume":"114","author":"Mumford","year":"2015","journal-title":"Thromb Haemostasis"},{"issue":"15","key":"10.1016\/j.cll.2024.04.011_bib102","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1182\/blood-2011-09-336933","article-title":"Transporters in human platelets: physiologic function and impact for pharmacotherapy","volume":"119","author":"Jedlitschky","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib103","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1038\/s41598-022-13037-z","article-title":"Flow cytometry based platelet activation markers and state of inflammation among subjects with type 2 diabetes with and without depression","volume":"12","author":"R","year":"2022","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.cll.2024.04.011_bib104","doi-asserted-by":"crossref","first-page":"18531","DOI":"10.1016\/S0021-9258(17)44784-3","article-title":"Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein","volume":"265","author":"Febbraio","year":"1990","journal-title":"J\u00a0Biol Chem"},{"issue":"14","key":"10.1016\/j.cll.2024.04.011_bib105","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","article-title":"Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol Cell"},{"issue":"6588","key":"10.1016\/j.cll.2024.04.011_bib106","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/382262a0","article-title":"Identification of the homologous beige and Chediak-Higashi syndrome genes","volume":"382","author":"Barbosa","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib107","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03402003","article-title":"The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins","volume":"8","author":"Tchernev","year":"2002","journal-title":"Mol Med"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib108","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A\u00a0prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/vox.12324","article-title":"Responsiveness of platelets during storage studied with flow cytometry--formation of platelet subpopulations and LAMP-1 as new markers for the platelet storage lesion","volume":"110","author":"Sodergren","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.cll.2024.04.011_bib110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fimmu.2019.00773","article-title":"Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome","volume":"10","author":"Lonati","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.cll.2024.04.011_bib111","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/rheumatology\/keaa092","article-title":"Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus","volume":"59","author":"Svenungsson","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib112","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/STROKEAHA.108.514687","article-title":"Platelet C4d is associated with acute ischemic stroke and stroke severity","volume":"39","author":"Mehta","year":"2008","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.cll.2024.04.011_bib113","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2006.02065.x","article-title":"Blood platelets activate the classical pathway of human complement","volume":"4","author":"Peerschke","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib114","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjh.13648","article-title":"Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor","volume":"173","author":"Peerschke","year":"2016","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.cll.2024.04.011_bib115","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2024.04.011_bib116","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood-2008-02-142125","article-title":"Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets","volume":"112","author":"Boylan","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-019-01852-7","article-title":"Variation in platelet expression of FcgammaRIIa after myocardial infarction","volume":"48","author":"McMahon","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0021-9150(02)00179-X","article-title":"Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis","volume":"164","author":"Calverley","year":"2002","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacc.2018.04.046","article-title":"FcgammaRIIa: a new cardiovascular risk marker","volume":"72","author":"Schneider","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cll.2024.04.011_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.a.24797","article-title":"OMIP-097: high-parameter phenotyping of human platelets by spectral flow cytometry","author":"Spurgeon","year":"2023","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib121","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1002\/cpz1.687","article-title":"Platelet phenotyping by full spectrum flow cytometry","volume":"3","author":"Spurgeon","year":"2023","journal-title":"Curr Protoc"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib122","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","article-title":"Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction","volume":"33","author":"Ault","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib123","first-page":"994","article-title":"Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement","volume":"80","author":"Gawaz","year":"1998","journal-title":"Thromb Haemostasis"},{"issue":"13","key":"10.1016\/j.cll.2024.04.011_bib124","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.CIR.102.13.1490","article-title":"Flow cytometric monitoring of glycoprotein IIb\/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine","volume":"102","author":"Peter","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2024.04.011_bib125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.thromres.2019.05.016","article-title":"Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia","volume":"180","author":"Althaus","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030296","article-title":"An optimized and standardized rapid flow cytometry functional method for heparin-induced thrombocytopenia","volume":"9","author":"Runser","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib127","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.CIR.94.3.279","article-title":"Platelet activation and coronary stent implantation. Effect of antithrombotic therapy","volume":"94","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib128","first-page":"346","article-title":"Flow cytometric analysis of platelet surface glycoproteins: phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia","volume":"110","author":"Michelson","year":"1987","journal-title":"J\u00a0Lab Clin Med"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08880019709030883","article-title":"Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of Bernard-Soulier syndrome","volume":"14","author":"Cohn","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.cll.2024.04.011_bib130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood.V68.1.173.173","article-title":"Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry","volume":"68","author":"Jennings","year":"1986","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib131","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.2009.015990","article-title":"Diagnosis of platelet-type von Willebrand disease by flow cytometry","volume":"95","author":"Giannini","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cll.2024.04.011_bib132","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/humu.23968","article-title":"Hermansky-Pudlak syndrome: mutation update","volume":"41","author":"Huizing","year":"2020","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib133","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2141.1997.1132938.x","article-title":"Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure","volume":"97","author":"Semple","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2024.04.011_bib134","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.1083","article-title":"Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome","volume":"44","author":"Albers","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.cll.2024.04.011_bib135","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1074\/jbc.M606479200","article-title":"Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets","volume":"282","author":"Smethurst","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.cll.2024.04.011_bib136","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cll.2024.04.011_bib137","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1073\/pnas.95.12.6642","article-title":"Cloning and characterization of human protease-activated receptor 4","volume":"95","author":"Xu","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"26","key":"10.1016\/j.cll.2024.04.011_bib138","doi-asserted-by":"crossref","first-page":"19728","DOI":"10.1074\/jbc.M909960199","article-title":"Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function","volume":"275","author":"Faruqi","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cll.2024.04.011_bib139","first-page":"1","article-title":"An optimized agonist peptide of protease-activated receptor 4 and its use in a validated platelet-aggregation assay","author":"Yang","year":"2022","journal-title":"Platelets"},{"issue":"9","key":"10.1016\/j.cll.2024.04.011_bib140","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1110\/ps.035568.108","article-title":"Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2","volume":"17","author":"Watson","year":"2008","journal-title":"Protein Sci"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:33:05Z","timestamp":1722429185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271224000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0272271224000222"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2024.04.011","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flow Cytometry and Platelets","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2024.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}